TIBEAY Biosciences
PrivateLast Round
VC Round
Apr 15, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
TIBEAY Biosciences operates in Healthcare & Life Sciences and is based in Nijmegen. Its latest recorded funding round was a VC Round in April 2026.
TIBEAY Biosciences is a biotechnology company that develops therapies for acute neurological conditions, such as its lead substance Ronopterin, which is designed to reduce secondary brain damage in patients with severe traumatic brain injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TIBEAY Biosciences Comparables
Compare TIBEAY Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrocyte Pharmaceuticals Inc. | 84% | |
| Gryphon Bio | 81% | |
| Nyrada Inc | 78% |
For institutional investors. Book with your work email.
TIBEAY Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
TIBEAY Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIG AG | VC Round |
| Athos KG | VC Round |
| Meneldor | VC Round |
| East Netherlands Development Agency (Oost NL) | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
$41M round led by Athos KG
For institutional investors. Book with your work email.
TIBEAY Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TIBEAY Biosciences's valuation, stock price, and market status.
Is TIBEAY Biosciences a public or private company?
TIBEAY Biosciences is a private company.
What is the current stock price of TIBEAY Biosciences?
TIBEAY Biosciences is a private company, so its shares have no public market price. Caplight tracks TIBEAY Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TIBEAY Biosciences worth (valuation)?
Valuation information for TIBEAY Biosciences is not publicly available.
Can I buy TIBEAY Biosciences stock?
TIBEAY Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TIBEAY Biosciences's last funding round?
TIBEAY Biosciences's most recent funding round was VC Round on April 15, 2026.
Who are the main investors in TIBEAY Biosciences?
Key investors in TIBEAY Biosciences include Athos KG.
Will TIBEAY Biosciences IPO soon?
No public IPO plans have been announced for TIBEAY Biosciences.
How can I track TIBEAY Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in TIBEAY Biosciences's shares on secondary markets.